Baseline Characteristics of Rheumatoid Arthritis Patients Starting Certolizumab Pegol Therapy And Glucocorticoid Prescription In The Eclair Study In 2012–2013

Journal article

Open access

Peer reviewed

A. Saraux, R. Flipo, F Fagnani, I. Bru, G. Cukierman, J. Joubert, W. Czarlewski, J. Dunkel, J. Massol and Bernard Combe

Value in Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, Vol.18(7)

11/2015

PMID: 26533573

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1016/j.jval.2015.09.2265View

Published (Version of record) Open

1 Record Views

Title: Baseline Characteristics of Rheumatoid Arthritis Patients Starting Certolizumab Pegol Therapy And Glucocorticoid Prescription In The Eclair Study In 2012–2013
Creators - without role: A. Saraux - Hôpital Maison Blanche
R. Flipo - Hôpital Roger Salengro
F Fagnani - Cemka-Eval
I. Bru - UCB Pharma
G. Cukierman - UCB Pharma
J. Joubert - UCB Pharma
W. Czarlewski - UCB Pharma
J. Dunkel - UCB Pharma
J. Massol - Département de Génétique et Reproduction
Bernard Combe - Hôpital Lapeyronie
Publication Details: Value in Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, Vol.18(7)
Identifiers: 9945251409311
Academic Unit: Institut de Génétique Moléculaire de Montpellier - IGMM
Language: English
Resource Type: Journal article
Local Fields: hal-01901128